Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-24-017719

Options or other derivatives

  • Director acquired 23,150 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ignelzi Troy A. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-20 Grant or award : show line 1 in the form Stock Option (right to buy) +23,150 23,150 D
Loading xslF345X05/rdgdoc.xml…